Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Wein

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|May 18, 2012
Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activitiesSergio A Caldarelli, Matthieu Hamel, Jean-Frédéric Duckert, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2008
Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malariaClemens H M Kocken, Edmond J Remarque, Martin A Dubbeld, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2017
High Accumulation and <i>In Vivo</i> Recycling of the New Antimalarial Albitiazolium Lead to Rapid Parasite DeathSharon Wein, Nicolas Taudon, Marjorie Maynadier, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 17, 2012
Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in miceMarli C Lombard, David D N'Da, Jaco C Breytenbach, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 6, 2010
Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursorsDelphine Margout, Florence Gattacceca, Georges Moarbess, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2010
Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarialsSergio A Caldarelli, Michel Boisbrun, Karine Alarcon, et al.
European Journal of Medicinal Chemistry|July 4, 2023
Purine containing carbonucleoside phosphonate analogues as novel chemotype for Plasmodium falciparum InhibitionBemba Sidi Mohamed, Minh Chau Nguyen, Sharon Wein, et al.
ACS Omega|July 20, 2018
Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6Mohamed D M Traoré, Vincent Zwick, Claudia A Simões-Pires, et al.
Science Advances|November 21, 2025
An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMPMarie Ali, Rea Dura, Marc-Antoine Guery, et al.
Journal of Medicinal Chemistry|January 24, 2025
Emoquine-1: A Hybrid Molecule Efficient against Multidrug-Resistant <i>Plasmodium</i> Parasites, Including the Artemisinin-Resistant Quiescent Stage, and Also Active In VivoYouzhi Li, Michel Nguyen, Marion Laurent, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|May 18, 2012
Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activitiesSergio A Caldarelli, Matthieu Hamel, Jean-Frédéric Duckert, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2008
Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malariaClemens H M Kocken, Edmond J Remarque, Martin A Dubbeld, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2017
High Accumulation and <i>In Vivo</i> Recycling of the New Antimalarial Albitiazolium Lead to Rapid Parasite DeathSharon Wein, Nicolas Taudon, Marjorie Maynadier, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 17, 2012
Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in miceMarli C Lombard, David D N'Da, Jaco C Breytenbach, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 6, 2010
Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursorsDelphine Margout, Florence Gattacceca, Georges Moarbess, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2010
Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarialsSergio A Caldarelli, Michel Boisbrun, Karine Alarcon, et al.
European Journal of Medicinal Chemistry|July 4, 2023
Purine containing carbonucleoside phosphonate analogues as novel chemotype for Plasmodium falciparum InhibitionBemba Sidi Mohamed, Minh Chau Nguyen, Sharon Wein, et al.
ACS Omega|July 20, 2018
Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6Mohamed D M Traoré, Vincent Zwick, Claudia A Simões-Pires, et al.
Science Advances|November 21, 2025
An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMPMarie Ali, Rea Dura, Marc-Antoine Guery, et al.
Journal of Medicinal Chemistry|January 24, 2025
Emoquine-1: A Hybrid Molecule Efficient against Multidrug-Resistant <i>Plasmodium</i> Parasites, Including the Artemisinin-Resistant Quiescent Stage, and Also Active In VivoYouzhi Li, Michel Nguyen, Marion Laurent, et al.
Pageof 5